Search

everythinglearnresearchcommunity

for

Search:↓

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

Skin symptoms can indicate endocrine disorders and have various treatments.

aPKCλ is essential for hair follicle stem cell maintenance and wound healing.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Platelet-Rich Plasma (PRP) increases the number of new hair follicles and speeds up hair formation.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Gene regulation could revolutionize hair color by altering pigmentation from within.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Blocking interferon-gamma might help treat various autoimmune diseases.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.